2 Become 1: FDA Takes Trip Down Combo Products Premarket Pathway In New Guidance
Executive Summary
The 28 January guidance from the US FDA explains the premarket and submission process for combination products and offers tips to manufacturers as they consider which of the agency’s lead centers should review their product.
You may also be interested in...
Combination Product Human Factors Final Guidance In Clearance, OCP Says
The OCP presented its priorities for 2023 and beyond at the RAPS/AFDO Combination Products Summit on 8 November.
Global Medtech Guidance Tracker: January 2022
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-eight documents have been posted on the tracker since its last update.
Compliance Corner: Having A Tight Grip On Suppliers Is Critical For Combination Product Manufacturers
Controlling vendors can be tricky for any manufacturer, but when you're a maker of combo drug-device products, it's doubly important to make sure suppliers are on the up-and-up. Experts from Johnson & Johnson and PAREXEL offer quick tips for keeping a watchful eye on vendors.